192 related articles for article (PubMed ID: 33067170)
1. Influence of aspirin use on clinical outcomes of patients with hepatocellular carcinoma: a meta-analysis.
Li X; Yu Y; Liu L
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101545. PubMed ID: 33067170
[TBL] [Abstract][Full Text] [Related]
2. Statin use and the prognosis of patients with hepatocellular carcinoma: a meta-analysis.
Li X; Liu L; Hu Y
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32162652
[TBL] [Abstract][Full Text] [Related]
3. Systematic review with meta-analysis: The effects of non-steroidal anti-inflammatory drugs and anti-platelet therapy on the incidence and recurrence of hepatocellular carcinoma.
Tan RZH; Lockart I; Abdel Shaheed C; Danta M
Aliment Pharmacol Ther; 2021 Aug; 54(4):356-367. PubMed ID: 34247393
[TBL] [Abstract][Full Text] [Related]
4. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
[TBL] [Abstract][Full Text] [Related]
5. Does aspirin reduce the incidence, recurrence, and mortality of hepatocellular carcinoma? A GRADE-assessed systematic review and dose-response meta-analysis.
Ma S; Qu G; Sun C; Liu H; Jiang Y; Li N; Wu B; Gao J; Feng L; Xie P; Xia W; Kim NH; Lowe S; Bentley R; Zhu Y; Zhou Q; Sun Y
Eur J Clin Pharmacol; 2023 Jan; 79(1):39-61. PubMed ID: 36334108
[TBL] [Abstract][Full Text] [Related]
6. Aspirin Use and the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B Virus or Hepatitis C Virus Infection: A Meta-Analysis of Cohort Studies.
Li X; Wu S; Yu Y
Front Med (Lausanne); 2020; 7():569759. PubMed ID: 33490093
[No Abstract] [Full Text] [Related]
7. Aspirin Use and the Risk of Hepatocellular Carcinoma: A Meta-analysis.
Wang Y; Wang M; Liu C; Wang W; Shi J; Dang S
J Clin Gastroenterol; 2022 Aug; 56(7):e293-e302. PubMed ID: 35316225
[TBL] [Abstract][Full Text] [Related]
8. Regular Aspirin Use Is Associated with a Reduced Risk of Hepatocellular Carcinoma (HCC) in Chronic Liver Disease: a Systematic Review and Meta-analysis.
Tan JL; Sidhu-Brar S; Woodman R; Chinnaratha MA
J Gastrointest Cancer; 2023 Jun; 54(2):325-331. PubMed ID: 35717551
[TBL] [Abstract][Full Text] [Related]
9. Aspirin Use Is Associated with a Reduced Incidence of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Memel ZN; Arvind A; Moninuola O; Philpotts L; Chung RT; Corey KE; Simon TG
Hepatol Commun; 2021 Jan; 5(1):133-143. PubMed ID: 33437907
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin.
Zeng RW; Yong JN; Tan DJH; Fu CE; Lim WH; Xiao J; Chan KE; Tan C; Goh XL; Chee D; Syn N; Tan EX; Muthiah MD; Ng CH; Tamaki N; Lee SW; Kim BK; Nguyen MH; Loomba R; Huang DQ
Aliment Pharmacol Ther; 2023 Mar; 57(6):600-609. PubMed ID: 36625733
[TBL] [Abstract][Full Text] [Related]
11. Aspirin Use and Mortality in Women With Ovarian Cancer: A Meta-Analysis.
Man X; Wang B; Tan Y; Yang X; Zhang S
Front Oncol; 2020; 10():575831. PubMed ID: 33598421
[TBL] [Abstract][Full Text] [Related]
12. The relationship between aspirin consumption and hepatocellular carcinoma: a systematic review and meta-analysis.
Wang S; Zuo L; Lin Z; Yang Z; Chen R; Xu Y
Eur J Med Res; 2023 Jul; 28(1):226. PubMed ID: 37422691
[TBL] [Abstract][Full Text] [Related]
13. Aspirin for the prevention of hepatocellular carcinoma: an updated meta-analysis with particular focus on patients with chronic liver disease.
Yi M; Feng X; Peng W; Teng F; Tang Y; Chen Z
Eur J Clin Pharmacol; 2022 Apr; 78(4):647-656. PubMed ID: 35032181
[TBL] [Abstract][Full Text] [Related]
14. Systematic Review and Meta-analysis: Association of Aspirin With Incidence of Hepatocellular Carcinoma.
Zhou X; Zhang T; Sun Y; Li C; Ding X; Zhu Y; Li L; Fan Z
Front Pharmacol; 2022; 13():764854. PubMed ID: 35300300
[No Abstract] [Full Text] [Related]
15. Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
Lee TY; Hsu YC; Tseng HC; Yu SH; Lin JT; Wu MS; Wu CY
JAMA Intern Med; 2019 May; 179(5):633-640. PubMed ID: 30882847
[TBL] [Abstract][Full Text] [Related]
16. The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies.
Yang WS; Va P; Bray F; Gao S; Gao J; Li HL; Xiang YB
PLoS One; 2011; 6(12):e27326. PubMed ID: 22205924
[TBL] [Abstract][Full Text] [Related]
17. A meta-analysis and systematic review: adjuvant interferon therapy for patients with viral hepatitis-related hepatocellular carcinoma.
Jiang S; Liu Y; Wang L; Duan C; Liu M
World J Surg Oncol; 2013 Sep; 11():240. PubMed ID: 24060218
[TBL] [Abstract][Full Text] [Related]
18. Nonsteroidal anti-inflammatory drugs, especially aspirin, are linked to lower risk and better survival of hepatocellular carcinoma: a meta-analysis.
Tao Y; Li Y; Liu X; Deng Q; Yu Y; Yang Z
Cancer Manag Res; 2018; 10():2695-2709. PubMed ID: 30147368
[TBL] [Abstract][Full Text] [Related]
19. Association of aspirin therapy with risk of hepatocellular carcinoma: A systematic review and dose-response analysis of cohort studies with 2.5 million participants.
Wang S; Yu Y; Ryan PM; Dang M; Clark C; Kontogiannis V; Rahmani J; Varkaneh HK; Salehisahlabadi A; Day AS; Zhang Y
Pharmacol Res; 2020 Jan; 151():104585. PubMed ID: 31816436
[TBL] [Abstract][Full Text] [Related]
20. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.
Cammà C; Schepis F; Orlando A; Albanese M; Shahied L; Trevisani F; Andreone P; Craxì A; Cottone M
Radiology; 2002 Jul; 224(1):47-54. PubMed ID: 12091661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
